Since EpCAM was the most abundant and consistent expressed TAA on PDAC patient tumor cells, the EpCAM-IgA antibody was tested in PMN ADCC assays with tumor cells and compared to PDAC cell lines. The gene discussed is CD79A; the disease is neoplasm.